These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30022431)

  • 1. Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.
    Yang WB; Chuang JY; Ko CY; Chang WC; Hsu TI
    Mol Neurobiol; 2019 Apr; 56(4):2301-2313. PubMed ID: 30022431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O
    Chang KY; Hsu TI; Hsu CC; Tsai SY; Liu JJ; Chou SW; Liu MS; Liou JP; Ko CY; Chen KY; Hung JJ; Chang WC; Chuang CK; Kao TJ; Chuang JY
    Redox Biol; 2017 Oct; 13():655-664. PubMed ID: 28822335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
    He Y; Kaina B
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair gene O
    Aasland D; Reich TR; Tomicic MT; Switzeny OJ; Kaina B; Christmann M
    J Neurochem; 2018 Jan; 144(2):139-151. PubMed ID: 29164620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
    Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
    Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data.
    Ye L; Gu L; Wang Y; Xing H; Li P; Guo X; Wang Y; Ma W
    CNS Neurosci Ther; 2024 Mar; 30(3):e14649. PubMed ID: 38448295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional control of O
    Happold C; Stojcheva N; Silginer M; Weiss T; Roth P; Reifenberger G; Weller M
    J Neurochem; 2018 Mar; 144(6):780-790. PubMed ID: 29480969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis.
    Chen TC; Chuang JY; Ko CY; Kao TJ; Yang PY; Yu CH; Liu MS; Hu SL; Tsai YT; Chan H; Chang WC; Hsu TI
    Redox Biol; 2020 Feb; 30():101413. PubMed ID: 31896509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.
    Mai A; Ye SW; Tu JY; Gao J; Kang ZF; Yao QM; Ting WJ
    Environ Toxicol; 2023 Jan; 38(1):90-100. PubMed ID: 36176197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells.
    Zampieri LX; Sboarina M; Cacace A; Grasso D; Thabault L; Hamelin L; Vazeille T; Dumon E; Rossignol R; Frédérick R; Sonveaux E; Lefranc F; Sonveaux P
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway.
    Zhang S; Lu Y; Li H; Ji Y; Fang F; Tang H; Qiu P
    Biosci Trends; 2020 May; 14(2):123-133. PubMed ID: 32173672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.
    Murphy SF; Varghese RT; Lamouille S; Guo S; Pridham KJ; Kanabur P; Osimani AM; Sharma S; Jourdan J; Rodgers CM; Simonds GR; Gourdie RG; Sheng Z
    Cancer Res; 2016 Jan; 76(1):139-49. PubMed ID: 26542214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.
    Chuang JY; Lo WL; Ko CY; Chou SY; Chen RM; Chang KY; Hung JJ; Su WC; Chang WC; Hsu TI
    Oncogenesis; 2017 May; 6(5):e339. PubMed ID: 28530704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.
    Reich TR; Schwarzenbach C; Vilar JB; Unger S; Mühlhäusler F; Nikolova T; Poplawski A; Baymaz HI; Beli P; Christmann M; Tomicic MT
    Cell Mol Life Sci; 2021 Jul; 78(14):5587-5604. PubMed ID: 34100981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated embryonic chondrocyte-expressed gene 1 promotes temozolomide resistance by modulating the SP1-MGMT axis in glioblastoma.
    Lv W; Li Q; Jia B; He Y; Ru Y; Guo Q; Li X; Lin W
    Am J Transl Res; 2021; 13(4):2331-2349. PubMed ID: 34017393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair.
    Xu H; Jin J; Chen Y; Wu G; Zhu H; Wang Q; Wang J; Li S; Grigore FN; Ma J; Chen CC; Lan Q; Li M
    Oncogene; 2022 Jul; 41(31):3876-3885. PubMed ID: 35780181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.
    De Salvo M; Maresca G; D'agnano I; Marchese R; Stigliano A; Gagliassi R; Brunetti E; Raza GH; De Paula U; Bucci B
    Int J Radiat Biol; 2011 May; 87(5):518-33. PubMed ID: 21405945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
    Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
    Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
    Yang B; Ma YB; Chu SH
    Cancer Gene Ther; 2018 Dec; 25(11-12):309-316. PubMed ID: 30140041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.